Prot #GO27820: A Randomized, Phase II, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Onartuzumab (MetMAb) in Combination with Paclitaxel + Cisplatin or Carboplatin as First-Line Treatment for Patients with Stage

Project: Research project

Project Details

StatusFinished
Effective start/end date11/26/12 → 11/26/15

Funding

  • PPD Development (Prot #GO27820 // Prot #GO27820)
  • Genentech, Inc (Prot #GO27820 // Prot #GO27820)